Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Current Deferred Revenue

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Current-Deferred-Revenue" stands at 141.44 Billion Japanese Yens as of 09/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -82.05 percent compared to the value the year prior.
The 1 year change in percent is -82.05.
The 3 year change in percent is -76.55.
The 5 year change in percent is -76.60.
The 10 year change in percent is -31.88.

The Serie's long term average value is 359.05 Billion Japanese Yens. It's latest available value, on 09/30/2024, is 60.61 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2010, to it's latest available value, on 09/30/2024, is +88.30%.
The Serie's change in percent from it's maximum value, on 09/30/2023, to it's latest available value, on 09/30/2024, is -82.05%.

Current Deferred Revenue for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Current Deferred Revenue905,699,262,464.00
LogoJohnson & Johnson - Current Deferred Revenue486,508,953,600.00
LogoAbbVie Inc - Current Deferred Revenue399,570,305,024.00
LogoRoche Holding AG - Current Deferred Revenue317,433,206,677.55
LogoAstraZeneca PLC - Current Deferred Revenue280,205,508,085.11